Loading clinical trials...
Loading clinical trials...
The objective of this Pilot Study is to verify the safety and efficacy of DMSB01 in the temporary improvement of Crow's Feet Lines
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Samyang Biopharmaceuticals Corporation
NCT06376838 · Crow's Feet Lines
NCT03408236 · Crow's Feet Lines
NCT04081402 · Crow's Feet Lines
NCT02248844 · Lateral Canthal Lines, Crow's Feet Lines
NCT01797081 · Lateral Canthus Rhytides, Crow's Feet Lines
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions